Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,075.69
+17.030.83%
Number of Gainers:618
Number of Losers:389
Number of Flat:17
PE:- -
High:2,083.23
Open:2,058.90
Low:2,058.90
Close:2,058.66
Volume:6.00B
Turnover:741.53B
Market Cap:96.63T
Float Cap:90.45T

Loading ...

Japan and South Korea Stock Markets Open Lower, KOSPI Falls 0.7%

Deep News
·
Sep 29

Global Bonds Approach 4% for First Time Since 2007 as US Rates Hit Two-Decade High

Deep News
·
Sep 29

Oracle Japan Earnings Call Highlights Cloud, AI Momentum

TIPRANKS
·
Sep 29

Samsung to inject US$1 billion into US AI infrastructure firm Helix Digital

Deep News
·
Sep 29

Apple Patches Critical iPhone Flaw Linked to Crypto Attacks

utoday
·
Sep 29

Hutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC

TIPRANKS
·
Sep 29

Hong Kong Stock Shareholding Disclosures: September 29

Stock News
·
Sep 29

CrowdStrike CEO George Kurtz Disposes of USD 5.08 Million in Common Shares

Reuters
·
Sep 29

Overnight Shock: Oil Prices Plunge, Trump Says U.S. and Iran Exchanged Messages via Intermediaries

Deep News
·
Sep 29

POSCO Seeks South Korean Government Approval for Nuclear Power Investment Plan

Deep News
·
Sep 29

Report: Goldman Sachs CEO David Solomon May Step Down Early by End of Next Year

Deep News
·
Sep 29

Belite Bio to Present Phase 3 Dragon Topline Results for Tinlarebant in Adolescent Stargardt Disease at Euretina

Reuters
·
Sep 29

I Tried Meta's Muse AI Agent. It's Helpful and Scary at the Same Time.

Dow Jones
·
Sep 29

Review & Preview: Rainy Days and Mondays

Dow Jones
·
Sep 29

Brightline Creditors Object to $258 Million Bankruptcy Loan

Dow Jones
·
Sep 29

CDT Equity Inc trading halted, news pending

TIPRANKS
·
Sep 29

Copper price holds above $14,400 as Chile strike risk grows

Mining
·
Sep 29

White Energy reshapes board, appoints veteran mining executive

TIPRANKS
·
Sep 29

Meta CEO Mark Zuckerberg Disposes of Meta Common Shares Worth $19.17 Million

Reuters
·
Sep 29

CSL Partners with AWS to Apply AI, Cloud Tools in Biopharma R&D

Reuters
·
Sep 29